Geier DA, Geier MR. 2004a. A comparative evaluation of the effects of MMR immunization and mercury doses from thimerosal-containing childhood vaccines on the population prevalence of autism. Med Sci Monit 10(3):PI33-9.

Geier D, Geier M. 2004b. Presentation to the Immunization Safety Review Committee. From Epidemiology, Clinical Medicine, Molecular Biology, and Atoms, to Politics: A Review of the Relationship between Thimerosal and Autism. Washington, DC.

Geier D, Geier M. 2004c. Submission to the Immunization Safety Review Committee. From Epidemiology, Clinical Medicine, Molecular Biology, and Atoms, to Politics: A Review of the Relationship Between Thimerosal and Autism.

General Biologics Product Standards. 2000. Constituent materials. 21 CFR. 2000;610.15.

Gillberg C, Heijbel H. 1998. MMR and autism. Autism. 2:423-4.

Gillberg C, Wing L. 1999. Autism: not an extremely rare disorder. Acta Psychiatr Scand 99(6):399-406.

Hill AB. 1965. The environment and disease: association or causation? Proc R Soc Med 58:295-300.

Hviid A, Stellfeld M, Wohlfahrt J, Melbye M. 2003. Association between thimerosal-containing vaccine and autism. JAMA 290(13):1763-6.

IOM (Institute of Medicine). 1991. Adverse Events Following Pertussis and Rubella Vaccines. Washington, DC: National Academy Press.

IOM. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: National Academy Press.

IOM. 2001a. Immunization Safety Review: Measles-Mumps-Rubella Vaccine and Autism. Washington, DC: National Academy Press.

IOM. 2001b. Immunization Safety Review: Thimerosal-Containing Vaccines and Neurodevelopmental Disorders. Washington, DC: National Academy Press.

IOM. 2002. Immunization Safety Review: Multiple Immunizations and Immune Dysfunction. Washington, DC: National Academy Press.

Kaye JA, del Mar Melero-Montes M, Jick H. 2001. Mumps, measles, and rubella vaccine and the incidence of autism recorded by general practitioners: a time trend analysis. British Med J 322(7284):460-3.

Madsen KM, Hviid A, Vestergaard M, Schendel D, Wohlfahrt J, Thorsen P, Olsen J, Melbye M. 2002. A population-based study of measles, mumps, and rubella vaccination and autism. N Engl J Med 347(19):1477-82.

Madsen KM, Lauritsen MB, Pedersen CB, Thorsen P, Plesner AM, Andersen PH, Mortensen PB. 2003. Thimerosal and the occurrence of autism: negative ecological evidence from Danish population-based data. Pediatrics 112(3 Pt 1):604-6.

Makela A, Nuorti JP, Peltola H. 2002. Neurologic disorders after measles-mumps-rubella vaccination. Pediatrics 110(5):957-63.

Miller E. 2004. Presentation to the Immunization Safety Review Committee. Thimerosal and Developmental Problems Including Autism. Washington, DC.

Murch SH, Anthony A, Casson DH, Malik M, Berelowitz M, Dhillon AP, Thomson MA, Valentine A, Davies SE, Walker-Smith JA. 2004. Retraction of an interpretation. Lancet 363:750.

NRC (National Research Council). 1989. Improving Risk Communication. Washington DC: National Academy Press.

NRC. 2000. Toxicological Effects of Methylmercury. Washington, DC: National Academy Press.

Patja A, Davidkin I, Kurki T, Kallio MJ, Valle M, Peltola H. 2000. Serious adverse events after measles-mumps-rubella vaccination during a fourteen-year prospective follow-up. Pediatr Infect Dis J 19(12):1127-34.

Peltola H, Patja A, Leinikki P, Valle M, Davidkin I, Paunio M. 1998. No evidence for measles, mumps, and rubella vaccine-associated inflammatory bowel disease or autism in a 14-year prospective study [letter]. Lancet 351(9112):1327-8.